Key facts
- This page summarizes Susan Molineaux's Form 4 filing for Calithera Biosciences, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 25 Jan 2023, 15:00.
Susan Molineaux - 23 Jan 2023 Form 4 Insider Report for Calithera Biosciences, Inc.
- Reporting relationship
- PRESIDENT & CEO, Director
- Issuer ticker
- N/A
- Reported as of
- 23 Jan 2023
- Net transaction value
- -$235
- SEC form
- 4
- Accepted by SEC
- 25 Jan 2023, 15:00:17 UTC
- Prior SEC filing
- 11 May 2022
- Next SEC filing
- 07 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Susan M. Molineaux
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Susan Molineaux filed Form 4 for Calithera Biosciences, Inc. on 25 Jan 2023.
Change
- Previous filing in this sequence was filed on 11 May 2022.
- Current net transaction value: -$235.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CALA
transaction
Common Stock
Tax liability
- Transaction value
- $235
- Shares
- -526
- Change %
- -1.9%
- Price
- $0.4461
- Shares after
- 27,859
- Date
- 23 Jan 2023
- Ownership
- By Trust
- Footnotes
- F1, F2, F3
CALA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,283
- Date
- 23 Jan 2023
- Ownership
- By Spouse
CALA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,724
- Date
- 23 Jan 2023
- Ownership
- Direct
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Footnote F2
The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on January 23, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
Footnote F3
Shares are held by the Molineaux Family Trust of which the Reporting Person is a Trustee.
Footnote F4
Includes 125 shares acquired on each of December 10, 2021, June 10, 2022 and December 9, 2022, under the Company's 2014 Employee Stock Purchase Plan.